Panel Recommends Warning for MRI Drug Agent Gadolinium
Touch Below for a free case review
Craig Swapp and Associates Free Consultation
Craig Swapp and Associates Free Consultation
Slide 1 Slide 2 Slide 3 Slide 4 Slide 5 Slide 6 Slide 7 Slide 8 Slide 9 Slide 10 Slide 11 Slide 12 Slide 13 Slide 14 Slide 15 Slide 16 Slide 17 Slide 18

Panel Recommends Warning for MRI Drug Agent Gadolinium

Today, a panel of advisers to the FDA made recommendations to the agency to put new warnings on MRI agents containing the drug Gadolinium, specifically for patients with kidney disease. The problem stems from the body trying to process the Gadolinium and remove it from the system. With kidneys that aren’t functioning optimally, the drug isn’t able to be expelled from the system, and a condition called Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy (NSF/NFD), can develop causing a host of problems. Among these problems are a slew of mild to debilitating Gadolinium side effects including burning, itching, swelling, thickening and hardening of the skin, dark spots on the skin, yellow spots on the eyes, pain deep in the ribs and hips, breathing difficulties, and muscle weakness. If you know of anyone experiencing these symptoms after an MRI, please contact us immediately and let us see how we can help. If you know of anyone going in for an MRI, ask if they have any type of kidney problem and make sure they don’t use a Gadolinium based agent.

Craig Swapp & Associates
9980 S 300 W Suite 400, Sandy, UT 84070
Map / Directions ? Phone Number: (800) 404-9000